Professor Mererid Evans qualified from the University of Wales, College of Medicine in 1994.
She undertook a MRC Clinical Training Fellowship researching Immune Responses against Human Papillomavirus (HPV) in patients with Cervical Cancer and was awarded a PhD by the University of Wales in 2001.
She was appointed Consultant in Clinical Oncology at Velindre Hospital in 2007, and undertook a Clinical Research Fellowship 2011-14, researching the role of HPV in the development of Head and Neck cancer in Wales and the UK.
Together with Professor Terry Jones at the University of Liverpool, she now leads a number of clinical trials, including:
PATHOS – a CR-UK funded phase II-III RCT aiming to prove that minimally invasive surgery and risk adapted post-operative radiotherapy/chemotherapy can reduce long term side-effects after treatment for HPV-associated Oropharyngeal Cancer (OPC).
Best-of – a CR-UK funded UK arm of a European phase III RCT aiming to define the best treatment (minimally invasive surgery or targeted radiotherapy) for patients with OPC.
PEARL – a Cancer Research Wales (CRW) and Velindre funded study of biologically adapted radiotherapy for patients with HPV-associated OPC.
She was awarded an Honorary Visiting Professorship by the University of Liverpool in 2016.